Daily Medication Pearl: Besifloxacin (Besivance)

Article

Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.

Medication Pearl of the Day: Besivance (besifloxacin)

Indication: Besifloxacin ophthalmic suspension (Besivance) 0.6% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.

Insight:

  • Dosing: Instill 1 drop in the affected eye(s) 3 times a day, 4 to 12 hours apart for 7 days.
  • Dosage forms:Ophthalmic suspension besifloxacin 6 mg/mL.
  • Adverse events: The most common adverse reaction reported in 2% of patients treated with Besivance was conjunctival redness.
  • Mechanism of action: Besifloxacin is a fluoroquinolone antibacterial agent.
  • Manufacturer: Bausch & Lomb Incorporated.

Sources:

Recent Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com